NCT04284774 2025-12-04Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting5 enrolled 9 charts
NCT00831844 2015-03-30Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed116 enrolled 8 charts
NCT00314925 2010-02-25Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine FeaturesNeotropixPhase 1 Unknown60 enrolled